BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9714476)

  • 1. HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population.
    Bateman AC; Turner SJ; Theaker JM; Howell WM
    Tissue Antigens; 1998 Jul; 52(1):67-73. PubMed ID: 9714476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
    Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
    Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DQB1*0301 association with increased cutaneous melanoma risk.
    Lee JE; Reveille JD; Ross MI; Platsoucas CD
    Int J Cancer; 1994 Nov; 59(4):510-3. PubMed ID: 7960221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alleles of HLA-DQB1 and familial aggregation of type 1 diabetes].
    Kubryn I; Młynarski W; Trippenbach-Dulska H; Szalecki M; Lisowicz L; Surdej B; Pilecki O; Heinrich A; Wyka K; Perenc M; Bodalski J
    Med Wieku Rozwoj; 2003; 7(2):157-64. PubMed ID: 12878786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population.
    Cavan DA; Jacobs KH; Penny MA; Kelly MA; Mijovic C; Jenkins D; Fletcher JA; Barnett AH
    Diabetologia; 1993 Mar; 36(3):252-7. PubMed ID: 8462775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population.
    Balducci-Silano PL; Layrisse Z; Dominguez E; Amaro R; Gunczler P; Lanes R; Zaro R
    Eur J Immunogenet; 1994 Dec; 21(6):405-14. PubMed ID: 9098450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
    Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
    Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?
    Skarsvåg S; Hansen KE; Holst A; Moen T
    Tissue Antigens; 1992 Sep; 40(3):128-33. PubMed ID: 1440567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China.
    Liu W; Li WM; Sun NL
    Ann Hum Genet; 2005 Jul; 69(Pt 4):382-8. PubMed ID: 15996167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles.
    Hu CY; Allen M; Chuang LM; Lin BJ; Gyllensten U
    Hum Immunol; 1993 Oct; 38(2):105-14. PubMed ID: 8106265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HLA-DRB1*0405 haplotype is most strongly associated with IDDM in Algerians.
    Djoulah S; Khalil I; Beressi JP; Benhamamouch S; Bessaoud K; Deschamps I; Degos L; Hors J
    Eur J Immunogenet; 1992 Dec; 19(6):381-9. PubMed ID: 1477090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of HLA DRB1 and DQB1 polymorphism in Italian melanoma patients.
    Lombardi ML; Mercuro O; Pirozzi G; Ionna F; Lombari V; Mozzillo N; Manzo C
    J Immunother; 1998 Nov; 21(6):435-9. PubMed ID: 9807738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients.
    Hodak E; Lapidoth M; Kohn K; David D; Brautbar B; Kfir K; Narinski N; Safirman S; Maron M; Klein K
    Br J Dermatol; 2001 Dec; 145(6):974-80. PubMed ID: 11899152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-encoded DQ alpha beta heterodimers confer susceptibility to myasthenia gravis disease.
    Khalil I; Berrih-Aknin S; Lepage V; Loste MN; Gajdos P; Hors J; Charron D; Degos L
    C R Acad Sci III; 1993 Jul; 316(7):652-60. PubMed ID: 8019886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region).
    Petrone A; Bugawan TL; Mesturino CA; Nisticò L; Galgani A; Giorgi G; Cascino I; Erlich HA; Di Mario U; Buzzetti R
    Tissue Antigens; 2001 Dec; 58(6):385-94. PubMed ID: 11929589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians.
    Drouet M; Delpuget-Bertin N; Vaillant L; Chauchaix S; Boulanger MD; Bonnetblanc JM; Bernard P
    Eur J Dermatol; 1998; 8(5):330-3. PubMed ID: 9683867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population.
    Huang HS; Peng JT; She JY; Zhang LP; Chao CC; Liu KH; She JX
    Hum Immunol; 1995 Dec; 44(4):210-9. PubMed ID: 8770634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II alleles confer susceptibility to recurrent fetal losses in Danish women.
    Christiansen OB; Rasmussen KL; Jersild C; Grunnet N
    Tissue Antigens; 1994 Oct; 44(4):225-33. PubMed ID: 7871523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Belgian Diabetes Registry.
    Van der Auwera B; Van Waeyenberge C; Schuit F; Heimberg H; Vandewalle C; Gorus F; Flament J
    Diabetes; 1995 May; 44(5):527-30. PubMed ID: 7729610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
    Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
    Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.